A novel antimicrobial approach based on the inhibition of zinc uptake in Salmonella enterica.

Andrea Battistoni, Serena Ammendola, Emilia Chiancone, Andrea Ilari

Journal: Future medicinal chemistry 2017;9(9):899-910

PMID: 28636417

Abstract

In this review we discuss evidences suggesting that bacterial zinc homeostasis represents a promising target for new antimicrobial strategies. The ability of the gut pathogen Salmonella enterica sv Typhimurium to withstand the host responses aimed at controlling growth of the pathogen critically depends on the zinc importer ZnuABC. Strains lacking a functional ZnuABC or its soluble component ZnuA display a dramatic loss of pathogenicity, due to a reduced ability to express virulence factors; withstand the inflammatory response; and compete with other gut microbes. Based on this data, ZnuA was chosen as a candidate for the rational design of novel antibiotics. Through a combination of structural and functional investigations, we have provided a proof of concept of the potential of this approach.

Address: Dipartimento di Biologia, Università di Roma Tor Vergata, Via della Ricerca Scientifica snc, 00133 Rome, Italy.; Dipartimento di Biologia, Università di Roma Tor Vergata, Via della Ricerca Scientifica snc, 00133 Rome, Italy.; CTIF, Center for TeleInFrastructures, Università di Roma Tor Vergata, Via della Ricerca Scientifica snc, 00133 Rome Italy.; Dipartimento di Scienze Biochimiche, Università Sapienza di Roma, P.le Aldo Moro 5, 00185 Rome, Italy.; Consiglio Nazionale delle Ricerche (CNR)-Istituto di Biologia e Patologia Molecolari (IBPM) c/o Dipartimento di Scienze Biochimiche, Università Sapienza di Roma, P.le Aldo Moro 5, 00185 Rome, Italy.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.